What does the evidence say? When Canada's health care decision-makers need to know, they ask CADTH. We're a trusted source for evidence on drugs and medical devices. How can we help you with your next decision?
Health Technology Update Issue 26 This issue of Health Technology Update features brief summaries of information on a broad range of medical technologies — from a robotic ... Last updated: January 10, 2020
Lasmiditan for the Acute Treatment of Migraine Methods These bulletins are not systematic reviews and do not involve critical appraisal or include a detailed summary of study f... Last updated: February 18, 2020
Minimally invasive therapies for benign prostatic hyperplasia (BPH) Summary This bulletin builds on a CADTH Rapid Response Report that critically appraises recent evidence on treatments to alleviate lo... Last updated: February 18, 2020
Cancellation of the 2020 CADTH Symposium A message from Dr. Brian O’Rourke, CADTH President and CEO, After carefully considering the evolving situation with COVID-19, and keepin... Event Date: April 18, 2020 - April 21, 2020
Patient Input and Clinical Experts: Luxturna CADTH has received the following notice(s) of pending drug submission(s). Brand name Luxturna Generic name voret... Published on: March 25, 2020
COVID-19: An Update From Dr. Brian O’Rourke, CADTH President and CEO For the latest updates and guidance on COVID-19, please consult the Public Health Agency of Canada. As our country deals with the COVID-... Published on: March 18, 2020
Call for Feedback: Drugs for the Treatment and Prevention of Osteoporosis in Postmenopausal Women A new project on Drugs for the Treatment and Prevention of Osteoporosis in Postmenopausal Women is now available for feedback from all in... Published on: March 5, 2020
